AMICUS THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements
AMICUS THERAPEUTICS, INC. reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements of $0 for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements · last filed 2022-11-07
- AMICUS THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, settlements for the quarter ending 2022-09-30 was $0.00.
- AMICUS THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, settlements for the quarter ending 2021-09-30 was -$6.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements 9 month |
|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 |
| 2021-09-30 | -$6.00M 10-Q · filed 2022-11-07 | -$6.00M 10-Q · filed 2022-11-07 |